January 18, 2022
M&A
  • Unilever PLC said it is looking to expand further into health after making a $68 billion bid for GlaxoSmithKline (GSK) PLC’s consumer health business. The acquisition would expand Unilever’s reach in oral care, vitamins, and over-the-counter medications. GSK plans to spin off its consumer health unit to focus more on drugs and vaccine development. (Articles here and here)
Return to Tea Leaves